| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) | 
|---|
| 08/02/2011 | CA2162957C Cinnamic acid derivative | 
| 07/28/2011 | WO2011088797A1 Intermediates of neutral endopeptidase inhibitors and preparation method thereof | 
| 07/28/2011 | US20110183925 Anti-inflammatory peptide | 
| 07/28/2011 | CA2786929A1 Intermediates of neutral endopeptidase inhibitors and preparation method thereof | 
| 07/27/2011 | CN201908055U Discoloration system for dihydrophenyl glycine synthesis process | 
| 07/27/2011 | CN201906607U Reaction device system used in dihydrobenzene glycine synthesis procedure | 
| 07/27/2011 | CN102137837A PAI-1 inhibitor | 
| 07/27/2011 | CN102134189A Process for the separation of organic and amino acids from fermentation broths | 
| 07/27/2011 | CN102134180A New loop opening hydrogenation reaction method for furan derivant | 
| 07/27/2011 | CN101486724B Preparation method of rare earth ternary complexes | 
| 07/27/2011 | CN101270061B Method for preparing glycine | 
| 07/26/2011 | US7985767 Therapeutic amides | 
| 07/26/2011 | CA2479514C Tumor imaging compounds | 
| 07/21/2011 | WO2011086566A1 Method of resolution of (rs) - 1, 1 ' - bi - 2 - naphthol for obtaining enantiomeric pure i.e. (s) - (-) " 1, 1 ' "bi - 2 -naphthol and/or (r) - ( ) - 1, 1 ' - bi - 2 - naphthol via co - crystal formation with optically active derivatives of gamma -amino acids | 
| 07/21/2011 | WO2011086565A1 Method for preparation of enantiomerically enriched and/or racemic gamma-amino acids | 
| 07/21/2011 | WO2010071988A8 Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging | 
| 07/21/2011 | US20110178316 Novel fullerene cyclopropanation reaction | 
| 07/21/2011 | US20110178267 Novel organic materials and methods for obtaining thereof | 
| 07/21/2011 | US20110178108 Group of amino substituted benzoyl derivatives and their preparation and their use | 
| 07/21/2011 | US20110178104 Anti-Heparin Compounds | 
| 07/21/2011 | US20110178088 Tetrahydro-naphthalene derivatives | 
| 07/21/2011 | US20110178087 Compositions and Their Use as Anti-Tumor Agents | 
| 07/21/2011 | US20110178084 Therapeutic compounds | 
| 07/21/2011 | US20110177316 Lyzable molded parts | 
| 07/21/2011 | US20110177154 Tubular nanostructure targeted to cell membrane | 
| 07/21/2011 | US20110176998 Imaging and therapy of virus-associated tumors | 
| 07/20/2011 | EP2345634A1 Optically active 4-amino-3-(4-chlorophenyl) butanoic acid | 
| 07/20/2011 | EP2345633A1 Optically active vinyl-cyclopropane carboxylic acid derivative and optically active vinyl-cyclopropane amino acid derivative manufacturing method | 
| 07/20/2011 | EP2344447A2 Gaba conjugates and methods of use thereof | 
| 07/20/2011 | EP1677767B1 Crystalline form of gamma-aminobutyric acid analog | 
| 07/20/2011 | EP1220841B1 Trifluoromethyl-substituted spirocyclic ketoenols | 
| 07/20/2011 | CN102126977A Method for preparing 5-aminosalicylic acid by adopting gas phase catalysis carboxylation method | 
| 07/20/2011 | CN102126976A Intermediates of Sitagliptin and preparation method thereof | 
| 07/20/2011 | CN102126975A Method and device for producing glutamic acid | 
| 07/20/2011 | CN102126974A Method for preparing monosodium glutamate directly from glutamic acid fermentation liquor | 
| 07/20/2011 | CN102126973A Meglumine compound of dibasic ester acid and preparation method and medicinal application thereof | 
| 07/20/2011 | CN102126972A Polyoxyethylene alkylphenol ether ester cationic gemini surfactant and preparation method thereof | 
| 07/20/2011 | CN102126971A Preparation method of gamma-aminobutyric acid | 
| 07/20/2011 | CN102126970A Methods for separating leucine and arginine by selective precipitation | 
| 07/20/2011 | CN102125822A Preparation method of heavy metal ion and precious metal ion resin in chelation adsorption water | 
| 07/20/2011 | CN101381324B Crystallization disassemble method of chiral alcohol based on schiff base coordination polymer | 
| 07/20/2011 | CN101186582B Method for separating and purifying phenylalanine from phenylalanine fermentation liquor | 
| 07/20/2011 | CN101100438B Technique for preparing L-homoserine | 
| 07/19/2011 | US7982066 High protein supplement | 
| 07/19/2011 | US7981930 Amantadine or rimantadine, and ribavirin or viramidine, and optionally a neuraminidase inhibitor such as oseltamivir, zanamivir, or peramivir | 
| 07/19/2011 | US7981856 Surfactant composition method for production thereof and cosmetic comprising said composition | 
| 07/19/2011 | CA2472713C N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists | 
| 07/14/2011 | WO2011041476A3 Biobased polyol cross-linkers for use in preparing polyesters and reversible polyurethanes | 
| 07/14/2011 | US20110172442 Amino acid derivative | 
| 07/14/2011 | US20110172324 Novel water soluble polyimide resin, its preparation and use | 
| 07/14/2011 | US20110172305 Endocannabinoids for Enhancing Growth and Development in Infants | 
| 07/14/2011 | US20110172303 Deacetylase inhibitors and uses thereof | 
| 07/14/2011 | US20110172240 Fatty acid fumarate derivatives and their uses | 
| 07/14/2011 | US20110171150 Monoester of n-undecylenoyl phenylalanine and polyol, method for preparing same, and use of said esters as a skin lightening agent | 
| 07/13/2011 | EP2343285A2 Peptoid compounds | 
| 07/13/2011 | EP2343270A2 New fluorinated compounds, their synthesis and use | 
| 07/13/2011 | EP2342175A1 Nitric oxide releasing amino acid ester compound, composition and method of use | 
| 07/13/2011 | EP2342173A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors | 
| 07/13/2011 | EP2341886A1 Antimicrobial n-chlorinated compositions | 
| 07/13/2011 | EP1509489B1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof | 
| 07/13/2011 | CN102120722A Method for recycling glutamic acid from desalting liquid | 
| 07/13/2011 | CN101531637B A novel compound capable of restraining and blocking M2 ion channel activity and application thereof | 
| 07/12/2011 | US7977507 Nateglinide crystals | 
| 07/12/2011 | US7977506 Amino acid for delivering active materials; bioavailability | 
| 07/12/2011 | CA2544305C Stable isotope-labeled aromatic amino acids, method for incorporating the same in target protein and method for nmr-structural analysis of proteins | 
| 07/12/2011 | CA2393312C Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. | 
| 07/07/2011 | WO2011079940A1 Solid containing glutamic acid-n, n-diacetic acid (glda) or a derivative therefrom and method for the production thereof | 
| 07/07/2011 | US20110166380 Derivative compounds of N-6-Trimethy-L-Lysine for therapeutic use | 
| 07/07/2011 | US20110166344 5,6-dihydro-1h-pyridin-2-one compounds | 
| 07/07/2011 | US20110166342 7-membered ring compound and method of production and pharmaceutical application thereof | 
| 07/07/2011 | US20110166025 Esteramide solvents/coalescing agents in phytosanitary, cleaning, degreasing, stripping, lubricating, coating, and pigment/ink compositions | 
| 07/07/2011 | US20110165076 Novel [f-18]- labelled l-glutamic acid and l-glutamine derivatives (i), use thereof and method for their production | 
| 07/07/2011 | DE102009060814A1 Verfahren zur Herstellung eines Feststoffs mit hinreichend geringer Hygroskopizität, der Glutaminsäure-N,N-diessigsäure (GLDA) oder ein Derivat davon enthält Provides procedures for the preparation of a solid having sufficiently low hygroscopicity, the glutamic acid-N, N-diacetic acid (GLDA) or a derivative thereof | 
| 07/07/2011 | CA2785865A1 Method for producing a solid with sufficiently low hygroscopicity which comprises glutamic acid-n,n-diacetic acid (glda) or a derivative thereof | 
| 07/06/2011 | EP2341044A1 Cycloalkylamine derivative | 
| 07/06/2011 | CN102119139A Process for production of bicyclo[2.2.2]octylamine derivative | 
| 07/06/2011 | CN102115450A Preparation method for 4-amino-3-phenylbutyric acid | 
| 07/06/2011 | CN102115449A Novel method for preparing pregabalin raceme hydrochloride | 
| 07/06/2011 | CN101386600B Process for producing phenylalanine derivative having quinazolinedione skeleton and intermediate for the same | 
| 07/05/2011 | US7973196 Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid | 
| 07/05/2011 | US7973181 Hydroxamic acid derivatives as inhibitors of HDAC enzymatic activity | 
| 07/05/2011 | US7973079 Methods and compounds for treating retinol-related diseases | 
| 07/05/2011 | CA2453845C Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy | 
| 06/30/2011 | WO2011077463A1 Process for preparing pregabalin and its intermediate | 
| 06/30/2011 | WO2011076915A1 Novel method for the preparation of (s)-pregabalin field of the invention | 
| 06/30/2011 | WO2011056620A8 Difunctional, amine-based surfactants, and their precursors, preparation, compositions and use | 
| 06/30/2011 | US20110160579 Microwave investigation with a contrast medium | 
| 06/30/2011 | US20110160252 Pharmaceutical compositions for treatment or prevention of hbv infection | 
| 06/30/2011 | US20110160127 Prodrugs of Neuraminidase Inhibitors | 
| 06/29/2011 | EP2338875A1 Process for the preparation of thyroid hormones and derivatives thereof | 
| 06/29/2011 | EP2338874A1 Process for the preparation of chelated compounds | 
| 06/29/2011 | EP1727786B1 Acid addition salts of 5-aminolevulinic acid or its derivatives | 
| 06/29/2011 | CN102112436A Novel and efficient method for synthesis of amino acid | 
| 06/29/2011 | CN102108055A Processing for recovering methyl anthranilate | 
| 06/28/2011 | US7968738 Compounds and methods for the treatment of cancer | 
| 06/23/2011 | WO2011073409A1 Process for the preparation of thyroid hormones and salts thereof | 
| 06/23/2011 | WO2011073236A1 Process for the preparation of chelated compounds | 
| 06/23/2011 | WO2010063403A8 Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation | 
| 06/23/2011 | US20110152573 Process for producing n-protected amino acid | 
| 06/23/2011 | US20110152572 Optically active 4-amino-3-(4-chlorophenyl)butanoic acid |